肝内胆管癌-话题@MedSci

#肝内胆管癌#

34篇内容 | 2531人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1296038, encodeId=ccdf129603835, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Liver Cancer：系统回顾和荟萃分析评估不可切除肝内胆管癌的放疗方式：体内或体外放疗？, objectType=article, longId=214550, objectId=a45e2145502c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a45e2145502c, replyNumber=0, likeNumber=101, createdTime=2021-07-23, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a45e2145502c, moduleTitle=Liver Cancer：系统回顾和荟萃分析评估不可切除肝内胆管癌的放疗方式：体内或体外放疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a45e2145502c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296037, encodeId=362f129603ee5, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！, objectType=article, longId=212789, objectId=f7f1212e899d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7f1212e899d, replyNumber=0, likeNumber=128, createdTime=2021-06-17, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7f1212e899d, moduleTitle=Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7f1212e899d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296036, encodeId=04be12960366a, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Clin Cancer Res：不同治疗方式和基因突变对肝内胆管癌患者预后的影响, objectType=article, longId=211261, objectId=62252112613d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62252112613d, replyNumber=0, likeNumber=75, createdTime=2021-05-15, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62252112613d, moduleTitle=Clin Cancer Res：不同治疗方式和基因突变对肝内胆管癌患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62252112613d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296035, encodeId=fc9a129603565, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, objectType=article, longId=211025, objectId=13fb211025c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13fb211025c6, replyNumber=0, likeNumber=76, createdTime=2021-05-11, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13fb211025c6, moduleTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13fb211025c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296034, encodeId=68841296034eb, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Eur Radiol：如何运用影像组学术前预测肝内胆管癌的无效切除？, objectType=article, longId=207550, objectId=056720e55018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=056720e55018, replyNumber=0, likeNumber=106, createdTime=2021-02-26, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=056720e55018, moduleTitle=Eur Radiol：如何运用影像组学术前预测肝内胆管癌的无效切除？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=056720e55018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296033, encodeId=462d129603381, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=J Gastroenterology：蛋白质组学分析确定TPI1是预测肝内胆管癌复发的新型生物标志物, objectType=article, longId=203403, objectId=99f32034034f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99f32034034f, replyNumber=0, likeNumber=103, createdTime=2020-11-16, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99f32034034f, moduleTitle=J Gastroenterology：蛋白质组学分析确定TPI1是预测肝内胆管癌复发的新型生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99f32034034f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296032, encodeId=2a201296032c0, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=和记黄埔启动HMPL-453治疗晚期肝内胆管癌的II期试验, objectType=article, longId=200232, objectId=130b2002327c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130b2002327c, replyNumber=0, likeNumber=101, createdTime=2020-09-05, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130b2002327c, moduleTitle=和记黄埔启动HMPL-453治疗晚期肝内胆管癌的II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130b2002327c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296031, encodeId=b14d129603130, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治, objectType=article, longId=198768, objectId=ea7b198e687d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea7b198e687d, replyNumber=0, likeNumber=80, createdTime=2020-08-07, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea7b198e687d, moduleTitle=Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea7b198e687d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296030, encodeId=0078129603019, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究, objectType=article, longId=197522, objectId=629b19e52265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=629b19e52265, replyNumber=0, likeNumber=0, createdTime=2020-07-16, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=629b19e52265, moduleTitle=JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=629b19e52265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296029, encodeId=b53f1296029a3, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系, objectType=article, longId=193721, objectId=7155193e210d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7155193e210d, replyNumber=0, likeNumber=82, createdTime=2020-05-09, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7155193e210d, moduleTitle=Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7155193e210d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296028, encodeId=79e412960285b, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现, objectType=article, longId=193179, objectId=833e1931e9c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=833e1931e9c2, replyNumber=0, likeNumber=104, createdTime=2020-05-01, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=833e1931e9c2, moduleTitle=AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=833e1931e9c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296027, encodeId=0399129602e09, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世, objectType=article, longId=189416, objectId=047d18941657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=047d18941657, replyNumber=0, likeNumber=88, createdTime=2020-03-07, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=047d18941657, moduleTitle=肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=047d18941657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296026, encodeId=9ee11296026ff, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！, objectType=article, longId=187798, objectId=7c9018e79870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c9018e79870, replyNumber=0, likeNumber=82, createdTime=2020-02-12, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c9018e79870, moduleTitle=Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c9018e79870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296025, encodeId=97d5129602561, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应, objectType=article, longId=164660, objectId=4d2816466030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d2816466030, replyNumber=0, likeNumber=63, createdTime=2019-04-22, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d2816466030, moduleTitle=Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d2816466030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296024, encodeId=0c4c129602489, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, objectType=article, longId=139533, objectId=a57d139533c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a57d139533c1, replyNumber=0, likeNumber=79, createdTime=2018-06-01, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a57d139533c1, moduleTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a57d139533c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296023, encodeId=8486129602395, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=J Hepatol：肝内胆管癌的时空演化, objectType=article, longId=133469, objectId=f66d133469b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f66d133469b6, replyNumber=0, likeNumber=0, createdTime=2018-03-27, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f66d133469b6, moduleTitle=J Hepatol：肝内胆管癌的时空演化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f66d133469b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296022, encodeId=c4ee1296022a1, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后, objectType=article, longId=132567, objectId=ecde13256ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecde13256ebe, replyNumber=0, likeNumber=60, createdTime=2018-03-17, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecde13256ebe, moduleTitle=Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecde13256ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296021, encodeId=da5d1296021cc, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！, objectType=article, longId=132227, objectId=d5b413222ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5b413222ed1, replyNumber=0, likeNumber=64, createdTime=2018-03-14, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5b413222ed1, moduleTitle=Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5b413222ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296020, encodeId=a1c0129602025, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究, objectType=article, longId=127628, objectId=fb3d12e628a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3d12e628a7, replyNumber=0, likeNumber=78, createdTime=2018-01-26, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3d12e628a7, moduleTitle=2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb3d12e628a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1296019, encodeId=d3171296019d2, content=<a href='/topic/show?id=ef11811e363' target=_blank style='color:#2F92EE;'>#肝内胆管癌#</a>, objectTitle=Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌, objectType=article, longId=74599, objectId=981fe4599f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981fe4599f3, replyNumber=0, likeNumber=57, createdTime=2016-08-08, rootId=0, userName=liuxiaona, userId=cb3a261, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981fe4599f3, moduleTitle=Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981fe4599f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝内胆管癌

2020-05-29

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Liver Cancer：系统回顾和荟萃分析评估不可切除肝内胆管癌的放疗方式：体内或体外放疗？

2021-07-23

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Hepatology：肝内胆管癌和肝细胞癌的临床特征和预后差异！

2021-06-17

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Clin Cancer Res：不同治疗方式和基因突变对肝内胆管癌患者预后的影响

2021-05-15

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后

2021-05-11

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Eur Radiol：如何运用影像组学术前预测肝内胆管癌的无效切除？

2021-02-26

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

J Gastroenterology：蛋白质组学分析确定TPI1是预测肝内胆管癌复发的新型生物标志物

2020-11-16

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

和记黄埔启动HMPL-453治疗晚期肝内胆管癌的II期试验

2020-09-05

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Journal of Translational Medicine：专家绘制出基于中国人群肝内胆管癌“基因图谱” 致力精准施治

2020-08-07

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

JAMA Surg：肝内胆管癌根治性切除术后早期复发预测模型研究

2020-07-16

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：女性外源性激素和生殖因素与肝内胆管癌风险的关系

2020-05-09

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

AACR 2020：肝内胆管癌的FGFR2一个新型突变被发现

2020-05-01

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

肝内胆管癌靶向治疗首次重大突破！Pemigatinib横空出世

2020-03-07

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：Nintedanib：肝内胆管癌的新福音——尼达尼布！

2020-02-12

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Hepatology：ID3促进干细胞特征并预测肝内胆管癌的化疗反应

2019-04-22

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响

2018-06-01

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

J Hepatol：肝内胆管癌的时空演化

2018-03-27

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Lancet Gastroenterology& Hepatology：进行新辅助化疗病情稳定的肝内胆管癌患者再进行肝移植或可改善预后

2018-03-17

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Brit J Cancer：吸烟、饮酒与肝细胞癌以及肝内胆管癌风险之间的关系！

2018-03-14

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

2018 ASCO-GI：仑伐替尼联合PD-1抑制剂治疗晚期肝内胆管癌疗效和安全性的初步研究

2018-01-26

liuxiaona (审核中...)

前往app查看评论内容

#肝内胆管癌#

Hepatology：极早期肝内胆管癌或许不再是肝移植禁忌

2016-08-08

科室
- - 订阅+
  - 更多科室
工具
服务